Collegium Pharmaceutical (COLL) Research Hub

Collegium Pharmaceutical (COLL) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 22.75 USD (-2.61%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 14.65, market cap 1.13B. This hub links to the full technical, earnings and options research available for COLL.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNASDAQ, US
Last close22.75 USD (-2.61%)
52-week range22.64 USD – 38.49 USD
Trend regimeRange
14-day RSI24.5 (Oversold)
Trailing P/E14.65
Market cap1.13B
Dividend yield0.00%
Next earnings2026-08-06

Available research for COLL

Earnings

COLL earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E 14.65. Updated 2026-07-23.

Options: Covered Call

Covered Call on COLL: how it works, illustrative setup around the real 22.75 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on COLL: how it works, illustrative setup around the real 22.75 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on COLL: how it works, illustrative setup around the real 22.75 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

COLL technical analysis: range, last 22.75 USD, RSI 24.5, 52w range 22.64 USD–38.49 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is COLL in?

Collegium Pharmaceutical (COLL) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.

Is COLL in an uptrend or downtrend?

As of 2026-09-11, COLL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is COLL's trailing P/E ratio?

COLL's trailing P/E is 14.65, with a market cap of 1.13B. See the earnings research page for full valuation detail.

When does COLL next report earnings?

COLL is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of 1.68 USD.